Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Titans in Mining: An Interview with Rick Rule, Part I

The Critical Investor sits down with Rick Rule, CEO of Sprott U.S. Holdings, for a wide-ranging discussion of his more than four-decade-long involvement in the resource sector. Several months ago I thought of something different. Wouldn't it be nice to interview the...

Trillion Energy (CSE:TCF) announces substantial 2022 year-end reserves report

Trillion Energy (TCF) has shared its third-party December 31, 2022 year-end reserves report Net present value of proved and probable (P2) natural gas reserves (NPV10%) increased to US$432 million net to Trillion, up from US$82 million (2021), a 426-per-cent ...

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...

Cannabis Firm's Stock Poised for 'Substantial Gains'

Technical analyst Clive Maund charts how news from this company affects its investment thesis. The reason for this brief update is that this is a good juncture to bring to your attention that the technical condition of Captiva Verde's stock continues to improve, to the ...

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...

Managed IT Services As A Money Saving Mechanism

Successful business owners realize the importance of reducing operating costs without affecting their company’s overall performance. Saving time and money is always a fundamental business goal, and it is more important than ever in small and midsize companies...

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug

Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report. In a June 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that the U.S. Food and Drug Administration (FDA) designated Axsome Therapeutics...

Is Canopy Growth a good stock to buy?

Canopy Growth Corp. (TSX:WEED) holds a prominent position in the Canadian cannabis industry, but is it a good stock to buy? Initially, the stock experienced remarkable growth, driven by the anticipation surrounding the legalization of recreational cannabis in ...

Going for Gold

In a recent Q&A article with Stockhouse , Nick Brodie, Chief Executive Officer of Galane Gold Ltd. (GG) ( TSX-V.GG , OTCQB: GGGOF , Forum ), sat down with our editorial staff to explain how his company is Company advancing its operations to meet the potential spike in ...

Analyst: Discovery of First Oil Is 'Company Making Event'

This event, its implications and near-term catalysts are discussed in a Pareto Securities report. In an Aug. 14, 2019 research note, Pareto Securities analyst Tom Erik Kristiansen reported that Eco Atlantic Oil & Gas Ltd. (EOG:TSX.V; ECAOF:OTCMKTS; ECO:LSE) ...
1 2 3 4 5 6 7 8 9 10 ...